Tag: US FDA New Drug Application
Aussie biotech firm completes bisantrene cGMP API manufacturing with Indian partner
Race Oncology Limited announced that Laurus Labs, an India-based pharmaceutical manufacturer, has produced its first batch of bisantrene dihydrochloride, Race’s active pharmaceutical ingredient (API), to a standard that meets the quality specified under the ‘Code of Good Manufacturing Practice’ (cGMP).
Featured Article
The future of steel engineering: Using CRM systems across supply chains
The construction industry has undergone significant transformation over the past twenty years. Speedpanel, a leading Australian manufacturer of lightweight, fire-rated, and acoustic wall systems, made a groundbreaking entrance in the early '90s, revolutionising the Australian construction landscape.
